These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16566900)

  • 1. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
    Otte C; Muhtz C; Daneshkhah S; Yassouridis A; Kiefer F; Wiedemann K; Kellner M
    Biol Psychiatry; 2006 Oct; 60(7):784-7. PubMed ID: 16566900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM; Mullen BC; Schatzberg AF
    Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary response to metyrapone in Gulf War veterans: relationship to deployment, PTSD and unexplained health symptoms.
    Golier JA; Schmeidler J; Yehuda R
    Psychoneuroendocrinology; 2009 Oct; 34(9):1338-45. PubMed ID: 19446401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.
    Otte C; Jahn H; Yassouridis A; Arlt J; Stober N; Maass P; Wiedemann K; Kellner M
    Life Sci; 2003 Aug; 73(14):1835-45. PubMed ID: 12888122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overnight suppression of HPA axis after mineraolocorticoid receptor stimulation: A sleep endocrine study.
    Demiralay C; Agorastos A; Jahn H; Kellner M; Yassouridis A; Wiedemann K
    Psychiatry Res; 2015 May; 227(1):65-70. PubMed ID: 25799272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans.
    Otte C; Yassouridis A; Jahn H; Maass P; Stober N; Wiedemann K; Kellner M
    J Gerontol A Biol Sci Med Sci; 2003 Oct; 58(10):B900-5. PubMed ID: 14570856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished cortisol levels in subordinate female marmosets are associated with altered central drive to the hypothalamic-pituitary-adrenal axis.
    Saltzman W; Hogan BK; Abbott DH
    Biol Psychiatry; 2006 Oct; 60(8):843-9. PubMed ID: 16499881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.
    Kellner M; Otte C; Yassouridis A; Schick M; Jahn H; Wiedemann K
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):337-9. PubMed ID: 15163445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder.
    Kanter ED; Wilkinson CW; Radant AD; Petrie EC; Dobie DJ; McFall ME; Peskind ER; Raskind MA
    Biol Psychiatry; 2001 Aug; 50(4):238-45. PubMed ID: 11522257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-end organ function in women with bipolar depression.
    Rasgon NL; Kenna HA; Wong ML; Whybrow PC; Bauer M
    Psychoneuroendocrinology; 2007 Apr; 32(3):279-86. PubMed ID: 17317022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Rao MN; Richards A; O'Donovan A; Gibson CJ; Baum T; Metzler TJ; Neylan TC
    Psychoneuroendocrinology; 2018 Feb; 88():136-143. PubMed ID: 29268182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cortisol awakening response in posttraumatic stress disorder.
    Wessa M; Rohleder N; Kirschbaum C; Flor H
    Psychoneuroendocrinology; 2006 Feb; 31(2):209-15. PubMed ID: 16154709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
    J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTSD and the HPA axis: differences in response to the cold pressor task among individuals with child vs. adult trauma.
    Santa Ana EJ; Saladin ME; Back SE; Waldrop AE; Spratt EG; McRae AL; LaRowe SD; Timmerman MA; Upadhyaya H; Brady KT
    Psychoneuroendocrinology; 2006 May; 31(4):501-9. PubMed ID: 16413134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metyrapone on hypothalamic-pituitary-adrenal axis and sleep in women with post-traumatic stress disorder.
    Otte C; Lenoci M; Metzler T; Yehuda R; Marmar CR; Neylan TC
    Biol Psychiatry; 2007 Apr; 61(8):952-6. PubMed ID: 17336940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
    Raubenheimer PJ; Young EA; Andrew R; Seckl JR
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):22-6. PubMed ID: 16817814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in the ACTH response to 24H metyrapone in depression.
    Young EA; Ribeiro SC
    Brain Res; 2006 Dec; 1126(1):148-55. PubMed ID: 16824495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder.
    Yehuda R; Levengood RA; Schmeidler J; Wilson S; Guo LS; Gerber D
    Psychoneuroendocrinology; 1996 Jan; 21(1):1-16. PubMed ID: 8778898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder.
    Ströhle A; Scheel M; Modell S; Holsboer F
    J Psychiatr Res; 2008 Oct; 42(14):1185-8. PubMed ID: 18342888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of posttraumatic stress disorder.
    Yehuda R
    J Clin Psychiatry; 2001; 62 Suppl 17():41-6. PubMed ID: 11495096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.